Last updated: February 11, 2024
Sponsor: Salem Veterans Affairs Medical Center
Overall Status: Completed
Phase
N/A
Condition
Dementia
Treatment
PAACC
REACH-VA
Clinical Study ID
NCT03447860
MS0010
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Caregivers will include family members living with the individual diagnosed withAlzheimer's Disease( AD) or Alzheimer's disease related dementia(ADRD) or TraumaticBrain Injury -AD(TBI-AD) with moderate to severe caregiver burden .
- Care recipients with diagnosis of Diagnosis of AD or ADRD or TBI-related AD .
Exclusion
Exclusion Criteria:
- Care givers: Determined to be an imminent risk to self or others,the Care recipientcurrently resides in a nursing home or assisted living facilities, unable to providetheir own consent to participate in the study , and active substance use disorder inthe last 1yr.
- Care recipient: Determined to be an imminent risk to self or others, Caregiver is notinterested in the study, unable to obtain informed consent from the Care recipient
Study Design
Total Participants: 142
Treatment Group(s): 2
Primary Treatment: PAACC
Phase:
Study Start date:
June 25, 2018
Estimated Completion Date:
November 12, 2023
Study Description
Connect with a study center
VA Boston Health Care system
Brockton, Massachusetts 02301
United StatesSite Not Available
Salem VAMC
Salem, Virginia 24153
United StatesSite Not Available
Salem Veteran Affairs Medical Center
Salem, Virginia 24153
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.